Overview

T/QT Study to Investigate the Effect of Relacorilant on Cardiac Repolarization in Healthy Volunteers

Status:
Completed
Trial end date:
2021-07-13
Target enrollment:
Participant gender:
Summary
This dedicated T/QT study will investigate the effect of relacorilant on cardiac repolarization in healthy participants.
Phase:
Phase 1
Details
Lead Sponsor:
Corcept Therapeutics
Treatments:
Moxifloxacin